We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

111 hedge funds and large institutions have $356M invested in Amphastar Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

0.52% less ownership

Funds ownership: 52.31% → 51.79% (-0.52%)

7% less funds holding

Funds holding: 119 → 111 (-8)

25% less capital invested

Capital invested by funds: $474M → $356M (-$118M)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $160K

Holders
111
Holders Change
-8
Holders Change %
-6.72%
% of All Funds
2.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
40
Reduced
34
Closed
18
Calls
–
Puts
$160K
Net Calls
-$160K
Net Calls Change
+$180K

Top Buyers

1
Federated Hermes
Federated Hermes
Pennsylvania
+$14.8M
2
Goldman Sachs
Goldman Sachs
New York
+$2.4M
3
State Street
State Street
Massachusetts
+$1.51M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.5M
5
BlackRock
BlackRock
New York
+$1.31M

Top Sellers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$10.1M
2
Invesco
Invesco
Georgia
-$6.24M
3
UBS AM
UBS AM
Illinois
-$4.34M
4
MSL
Mackay Shields LLC
New York
-$3.46M
5
MCM
Matarin Capital Management
New York
-$2.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$92.1M +$1.31M +75,111 +1%
Federated Hermes
2
Federated Hermes
Pennsylvania
$38.6M +$14.8M +852,213 +49%
Vanguard Group
3
Vanguard Group
Pennsylvania
$35.4M +$351K +20,146 +0.9%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$27.4M +$673K +38,675 +2%
State Street
5
State Street
Massachusetts
$17.8M +$1.51M +86,792 +8%
Invesco
6
Invesco
Georgia
$11M -$6.24M -358,845 -33%
Renaissance Technologies
7
Renaissance Technologies
New York
$11M -$1.64M -94,400 -11%
Goldman Sachs
8
Goldman Sachs
New York
$8.45M +$2.4M +138,224 +32%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$7.92M +$509K +29,250 +6%
VOYA Investment Management
10
VOYA Investment Management
Georgia
$7.84M -$549K -31,553 -6%
Northern Trust
11
Northern Trust
Illinois
$7.43M +$83.7K +4,812 +1%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$5.54M -$275K -15,785 -4%
EAM
13
Eagle Asset Management
Florida
$4.72M +$587K +33,752 +12%
Marshall Wace
14
Marshall Wace
United Kingdom
$4.48M +$137K +7,846 +3%
Ameriprise
15
Ameriprise
Minnesota
$4.38M -$290K -16,655 -5%
SAM
16
Silvercrest Asset Management
New York
$4.32M -$155K -8,918 -3%
RCAMU
17
Rothschild & Co Asset Management US
Connecticut
$4.22M -$861K -49,461 -15%
Nordea Investment Management
18
Nordea Investment Management
Sweden
$4.03M +$258K +14,806 +6%
Principal Financial Group
19
Principal Financial Group
Iowa
$3.86M -$187K -10,752 -4%
Morgan Stanley
20
Morgan Stanley
New York
$3.48M +$1.12M +64,551 +38%
Charles Schwab
21
Charles Schwab
California
$3.27M +$69.3K +3,983 +2%
MAM
22
Martingale Asset Management
Massachusetts
$3.16M +$55.3K +3,179 +2%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$2.54M -$145K -8,339 -5%
N
24
Nuveen
North Carolina
$2.05M -$6.79K -390 -0.3%
Bank of Montreal
25
Bank of Montreal
Ontario, Canada
$1.72M -$92.9K -5,342 -4%
1
2 3 4 5

AMPH Hedge Fund Activity: Q1 2020 in Review

111 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q1 2020, worth a combined $356M — down 25% from $474M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of AMPH and 12 opened new positions — a net loss of 6 holders — while 34 trimmed existing stakes and 40 added.

The largest buyer was Federated Hermes, adding an estimated $14.8M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $10.1M sold.

  • 111 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q1 2020, down from 119 in Q4 2019.
  • Funds reported $356M of Amphastar Pharmaceuticals stock for Q1 2020, down 25% quarter-over-quarter.
  • 12 funds opened new Amphastar Pharmaceuticals positions in Q1 2020 and 18 closed out, a net change of -6 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q1 2020 was Federated Hermes, an estimated $14.8M added.
  • The largest Amphastar Pharmaceuticals seller in Q1 2020 was Arrowstreet Capital, an estimated $10.1M sold.

Based on aggregated 13F filings for Q1 2020.